Reuters logo
BRIEF-Neos Therapeutics enters into a license agreement with Shire
March 10, 2017 / 9:24 PM / 8 months ago

BRIEF-Neos Therapeutics enters into a license agreement with Shire

March 10 (Reuters) - Neos Therapeutics Inc

* On March 6, 2017, Neos Therapeutics entered into a license agreement with Shire - SEC filing

* Pursuant to deal Shire granted to Co non-exclusive license to certain patents owned by Shire for activities with respect to NT-0201

* Company will also pay a single digit royalty on net sales of NT-0201 during life of Shire patents

* Agreement contains covenant from Shire not to file a patent infringement suit against Co alleging NT-0201 would infringe Shire patents

* Under terms of license agreement, Co is required to pay lump sum, license fee of less than $1.0 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below